Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. OSCR
stocks logo

OSCR

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
3.11B
+30.16%
-0.916
+47.72%
3.21B
+5.52%
0.620
-32.61%
3.22B
+12.47%
-0.060
-93.26%
Estimates Revision
The market is revising Downward the revenue expectations for Oscar Health, Inc. (OSCR) for FY2025, with the revenue forecasts being adjusted by -0.25% over the past three months. During the same period, the stock price has changed by -11.58%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.25%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-6.02%
In Past 3 Month
Stock Price
Go Down
down Image
-11.58%
In Past 3 Month
Wall Street analysts forecast OSCR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSCR is 16.06 USD with a low forecast of 11.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast OSCR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSCR is 16.06 USD with a low forecast of 11.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
3 Sell
Moderate Sell
Current: 17.180
sliders
Low
11.00
Averages
16.06
High
25.00
Current: 17.180
sliders
Low
11.00
Averages
16.06
High
25.00
Piper Sandler
Neutral -> Overweight
upgrade
$13 -> $25
2025-11-25
Reason
Piper Sandler
Price Target
$13 -> $25
2025-11-25
upgrade
Neutral -> Overweight
Reason
Piper Sandler upgraded Oscar Health to Overweight from Neutral with a price target of $25, up from $13.
Piper Sandler
Jessica Tassan
Neutral -> Overweight
upgrade
$13 -> $25
2025-11-25
Reason
Piper Sandler
Jessica Tassan
Price Target
$13 -> $25
2025-11-25
upgrade
Neutral -> Overweight
Reason
As previously reported, Piper Sandler analyst Jessica Tassan upgraded Oscar Health to Overweight from Neutral with a price target of $25, up from $13. Following a deep dive into benefit design, pricing and broker strategy in Miami-Dade, Oscar's largest county, the firm believes Oscar can concurrently grow share and profitability in a scenario where E-APTCs expire at the end of calendar 2025. The firm considers calendar year 2027 adjusted EBITDA of $404M to be "the floor," the analyst tells investors.
Wells Fargo
Underweight
downgrade
$14 -> $11
2025-11-13
Reason
Wells Fargo
Price Target
$14 -> $11
2025-11-13
downgrade
Underweight
Reason
Wells Fargo lowered the firm's price target on Oscar Health to $11 from $14 on lower odds for enhanced subsidy extension, while keeping an Underweight rating on the shares. The firm is updating estimates and model assumptions following Q3 and greater visibility into 2026 market dynamics. Wells sees Oscar Health as a clear share gainer in 2026, making it harder to underwrite MLR improvement.
Barclays
Andrew Mok
Underweight
maintain
$11 -> $13
2025-11-10
Reason
Barclays
Andrew Mok
Price Target
$11 -> $13
2025-11-10
maintain
Underweight
Reason
Barclays analyst Andrew Mok raised the firm's price target on Oscar Health to $13 from $11 and keeps an Underweight rating on the shares following the Q3 report. The company is putting though a weighted-average rate increase of 28%, with more competitive products in bronze and gold tiers, the analyst tells investors in a research note.
UBS
Sell
maintain
$11 -> $12
2025-11-07
Reason
UBS
Price Target
$11 -> $12
2025-11-07
maintain
Sell
Reason
UBS raised the firm's price target on Oscar Health to $12 from $11 and keeps a Sell rating on the shares.
Goldman Sachs
Neutral
initiated
$17
2025-10-14
Reason
Goldman Sachs
Price Target
$17
2025-10-14
initiated
Neutral
Reason
Goldman Sachs initiated coverage of Oscar Health with a Neutral rating and $17 price target. The managed care industry faces its most significant underwriting downturn in over 15 years, the analyst tells investors in a research note. Goldman recommends increased exposure to Medicare Advantage as it sees a margin recovery phase beginning in 2026. However, the firm does not see the Medicare Advantage recovery playing out uniformly across the group in 2026. The analyst also sees a longer path to cyclical recovery in Medicaid and the healthcare exchange.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Oscar Health Inc (OSCR.N) is -33.09, compared to its 5-year average forward P/E of 25.57. For a more detailed relative valuation and DCF analysis to assess Oscar Health Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
25.57
Current PE
-33.09
Overvalued PE
90.18
Undervalued PE
-39.04

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-9.50
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
49.06
Undervalued EV/EBITDA
-68.06

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.50
Current PS
0.00
Overvalued PS
1.01
Undervalued PS
-0.01
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

OSCR News & Events

Events Timeline

(ET)
2025-12-02
12:30:00
Oscar Health (OSCR) Shares Rise 0.39% with Bullish Options Flow
select
2025-11-24 (ET)
2025-11-24
12:00:24
Oscar Health Shares Surge by 20.7%
select
2025-11-24
10:00:06
Oscar Health Shares Surge by 24.8%
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
6.5
13:00 PMBenzinga
Mark Cuban Calls Current Obamacare 'Garbage,' Blames Politicians for Its Failures

  • Mark Cuban's Accusations: Mark Cuban criticized major insurers for exploiting independent physicians through practices like denying and underpaying claims, which he argues leads to financial strain on small providers and ultimately harms patient care.

  • Concerns Over the Affordable Care Act: Cuban described the Affordable Care Act (ACA) as having deteriorated over 15 years, becoming susceptible to corporate manipulation, and called for a complete overhaul rather than temporary fixes.

  • Political Context: Cuban's comments come amid ongoing political debates regarding ACA subsidies, with Republicans pushing to end them and Democrats advocating for extensions to prevent premium hikes.

  • Market Impact: The article also highlights stock performance of various health insurance companies, indicating a mixed year-to-date change, reflecting the ongoing uncertainty in the healthcare market.

[object Object]
Preview
4.5
11-27NASDAQ.COM
Tech Stocks Propel Overall Market Upward

  • Market Performance: The S&P 500, Dow Jones, and Nasdaq 100 all closed higher on Wednesday, with the S&P reaching a two-week high, driven by strength in semiconductor stocks and optimism about a potential Fed rate cut.

  • Economic Indicators: Weekly jobless claims fell to a seven-month low, and capital goods orders rose more than expected, contributing to positive market sentiment, while the Chicago PMI indicated a significant contraction.

  • Corporate Earnings: Q3 earnings for S&P 500 companies showed strong performance, with 83% exceeding forecasts and an overall increase of 14.6%, marking the best quarter since 2021.

  • Stock Movements: Notable gainers included Urban Outfitters and Robinhood, while Ambarella and Nutanix faced significant declines due to disappointing forecasts and earnings reports.

[object Object]
Preview
8.0
11-27Benzinga
Options Corner: Concerns Over AI Bubble Prompt Strategic Bet on Tech Leader Microsoft

  • Market Sentiment on Microsoft: Despite signs of recovery in the tech sector, skepticism persists, particularly regarding Microsoft Corp (MSFT) amid fears of a potential AI bubble burst, leading to cautious trading behavior.

  • Options Trading Strategy: A specific options trade involving a bull call spread for MSFT suggests a potential 108% payout if the stock reaches $500, indicating a bullish sentiment despite market uncertainties.

  • Analytical Approach: The article emphasizes the need for a rigorous analytical methodology to navigate the complexities of the stock market, advocating for a probabilistic approach rather than traditional linear models.

  • Caution Against Bias: It warns against relying solely on fundamental or technical analysis, suggesting that true market insights come from understanding mathematical realities and recognizing patterns in high-dimensional data.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Oscar Health Inc (OSCR) stock price today?

The current price of OSCR is 17.18 USD — it has increased 0.47 % in the last trading day.

arrow icon

What is Oscar Health Inc (OSCR)'s business?

Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.

arrow icon

What is the price predicton of OSCR Stock?

Wall Street analysts forecast OSCR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSCR is 16.06 USD with a low forecast of 11.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Oscar Health Inc (OSCR)'s revenue for the last quarter?

Oscar Health Inc revenue for the last quarter amounts to 2.99B USD, increased 23.21 % YoY.

arrow icon

What is Oscar Health Inc (OSCR)'s earnings per share (EPS) for the last quarter?

Oscar Health Inc. EPS for the last quarter amounts to -0.53 USD, increased 140.91 % YoY.

arrow icon

What changes have occurred in the market's expectations for Oscar Health Inc (OSCR)'s fundamentals?

The market is revising Downward the revenue expectations for Oscar Health, Inc. (OSCR) for FY2025, with the revenue forecasts being adjusted by -0.25% over the past three months. During the same period, the stock price has changed by -11.58%.
arrow icon

How many employees does Oscar Health Inc (OSCR). have?

Oscar Health Inc (OSCR) has 2400 emplpoyees as of December 05 2025.

arrow icon

What is Oscar Health Inc (OSCR) market cap?

Today OSCR has the market capitalization of 4.55B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free